Comprehensive Evaluation of Visual Function

NCT ID: NCT00894192

Last Updated: 2009-05-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

300 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-02-28

Study Completion Date

2009-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess the level of visual functioning in patients with various eye conditions while wearing different types of eyeglasses.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of the research is to study the level of visual functioning in individuals with various eye conditions when using different types of eyeglass lenses. Therefore, the goal of this study is to determine factors that may account for variability in the visual functioning of individuals with a range of refractive errors and their ability to perform everyday activities when equipped with different types of lenses. We hypothesize that the subjects will perform visual tasks of function better when using iZon™ Wavefront-Guided Glasses than with conventional glasses. This hypothesis is based upon the glasses yielding better visual acuity and because the design of the glasses reduces the effects of glare. This research is important so that alternate treatments and vision correction may be implemented which will have a more beneficial impact on those with refractive errors and visual impairment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Visual Function

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Wavefront guided lenses

Group Type ACTIVE_COMPARATOR

Izon Wavefront-guided lenses

Intervention Type DEVICE

Subjects will use prescribed eyeglasses for one week. Their visual functioning will be tested at the end of the week.

Conventional lenses

Group Type PLACEBO_COMPARATOR

Conventional lenses

Intervention Type DEVICE

We will test the subjects with these lenses after they have worn them for one week. Same procedures will be followed as with the other lenses.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Izon Wavefront-guided lenses

Subjects will use prescribed eyeglasses for one week. Their visual functioning will be tested at the end of the week.

Intervention Type DEVICE

Conventional lenses

We will test the subjects with these lenses after they have worn them for one week. Same procedures will be followed as with the other lenses.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Have normal vision
* Are far-sighted or near-sighted
* Have no eye diseases Subjects aged 18 and over, who have refractive errors ranging from +5.0 to -5.0 and/or who have eye disease will be included in the study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ophthonix Inc

INDUSTRY

Sponsor Role collaborator

University of Illinois at Chicago

OTHER

Sponsor Role collaborator

The Chicago Lighthouse

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

The Chicago Lighthouse

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Chicago Lighthouse

Chicago, Illinois, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Samar Suleman, BA

Role: CONTACT

312-447-3234

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Samar Suleman, BA

Role: primary

312-447-3234

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

OPH-2005-0516

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.